1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNCI Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs is sponsored by National Cancer Institute (NCI). These programs encourage small businesses to engage in research and development that has the potential for commercialization.
Get alerted about grants like this
Save a search for “National Cancer Institute (NCI)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The SBIR and STTR programs were reauthorized on April 13, 2026. Currently, NIH has no active SBIR or STTR Notices of Funding Opportunity (NOFOs). Future NOFOs are forecasted at Grants.
gov prior to opening for applications. The next standard receipt date is September 5, 2026. Going Beyond Funding for Next-Generation Cancer Technologies Boosting the Economy and Driving Innovation Between 1998 and 2018, NCI SBIR/STTR awardees fueled $26.
1 billion in economic output, 100,000+ jobs, and breakthrough cancer technologies. Latest Opportunities with SBIR NCI STEP Deadline Approaching Apply for SBIR/STTR application support and entrepreneurship training through NCI STEP by at Friday, May 15, 2026. Upcoming ASGCT Poster Presentation Connect with the NCI SBIR team during the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting.
Biomedical researchers at Illumina are developing next-generation tools to analyze genetic variation and function on a massive scale. Illumina used NCI SBIR funding to develop their next generation sequencing technology.
According to the current listing, eligibility includes: Small business concerns. Universities can participate as sub-awardees or through collaborative agreements with eligible small businesses. Confirm the full requirements in the official notice before applying.
NCI Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
NIH NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) is a grant from the National Institutes of Health (NIH) / National Cancer Institute (NCI) that funds early-stage postdoctoral researchers in cancer-related fields to transition to independent research careers. The award provides a mentored phase (K99) followed by an independent phase (R00), supporting investigators who do not require an extended period of supervised training beyond their doctoral degrees. Eligible applicants must hold a research or clinical doctoral degree and be postdoctoral fellows who have not yet established independent research careers. The March 11, 2026 due date applies; award amounts vary by project.